Skip to main content
SpringerLink
Log in
Book cover

Bronchiectasis pp 39–49Cite as

Clinical Aspects

  • Chapter
  • First Online:

  • 1069 Accesses

Abstract

Bronchiectasis is a heterogeneous disease that presents a wide range of clinical manifestations from asymptomatic to massive haemoptysis and respiratory failure. With the widespread availability of chest computed tomography, clinicians encounter bronchiectasis more frequently in various degrees of severity and symptom burden, even in asymptomatic patients [1]. It remains to be established what the significance is of bronchiectatic lesions in asymptomatic patients. Additionally, in milder disease, the diagnosis relies on radiographic bronchial/arterial ratios, which may lead to an overestimation of cylindrical bronchiectasis due to small vascular calibres in certain patient populations [2]. For those patients that have symptomatic bronchiectasis, the most common symptom is cough, occurring in 82–96% of patients [3–6]. In fact, cough may be the only symptom for many years. Other common symptoms include daily sputum production, dyspnoea and chest pain (Table 4.1). The frequency and severity of symptoms are often related to the extent of the bronchiectasis and the coexistence with other respiratory or systemic diseases [5]. Sputum production may be affected by recurrent infections, the use of airway clearance devices, antibiotics and other therapies [7]. Patients often report frequent pulmonary infections, although a single severe respiratory infection may result in bronchiectasis. Haemoptysis occurs in 26–51% of the cases often presenting in mild fashion, but can result in shock or respiratory failure if it is massive [3–6].

This is a preview of subscription content, log in via an institution.

References

  1. Kwak HJ, Moon JY, Choi YW, et al. High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program. Tohoku J Exp Med. 2010;222:237–42.

    Article  PubMed  Google Scholar 

  2. Diaz AA, Young TP, Maselli DJ, et al. Bronchoarterial ratio in never-smokers adults: implications for bronchial dilation definition. Respirology. 2017;22:108–13.

    Article  PubMed  Google Scholar 

  3. King PT, Holdsworth SR, Freezer NJ, et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100:2183–9.

    Article  PubMed  Google Scholar 

  4. Nicotra MB, Rivera M, Dale AM, et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 1995;108:955–61.

    Article  CAS  PubMed  Google Scholar 

  5. Habesoglu MA, Ugurlu AO, Eyuboglu FO. Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis. Ann Thorac Med. 2011;6:131–6.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dimakou K, Triantafillidou C, Toumbis M, et al. Non CF-bronchiectasis: aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir Med. 2016;116:1–7.

    Article  PubMed  Google Scholar 

  7. Lee AL, Burge AT, Holland AE. Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev. 2015;11:CD008351.

    Google Scholar 

  8. Guilemany JM, Angrill J, Alobid I, et al. United airways again: high prevalence of rhinosinusitis and nasal polyps in bronchiectasis. Allergy. 2009;64:790–7.

    Article  CAS  PubMed  Google Scholar 

  9. Braunstahl GJ. The unified immune system: respiratory tract-nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol. 2005;115:142–8.

    Article  CAS  PubMed  Google Scholar 

  10. Goeminne PC, Scheers H, Decraene A, et al. Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir Res. 2012;13:21.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Olveira C, Olveira G, Gaspar I, et al. Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res. 2013;22:597–605.

    Article  PubMed  Google Scholar 

  12. Giron Moreno RM, Fernandes Vasconcelos G, Cisneros C, et al. Presence of anxiety and depression in patients with bronchiectasis unrelated to cystic fibrosis. Arch Bronconeumol. 2013;49:415–20.

    Article  PubMed  Google Scholar 

  13. Brill SE, Patel AR, Singh R, et al. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir Res. 2015;16:16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kapur N, Masters IB, Chang AB. Exacerbations in noncystic fibrosis bronchiectasis: clinical features and investigations. Respir Med. 2009;103:1681–7.

    Article  PubMed  Google Scholar 

  15. Edwards EA, Metcalfe R, Milne DG, et al. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships. Pediatr Pulmonol. 2003;36:87–93.

    Article  CAS  PubMed  Google Scholar 

  16. Guan WJ, Gao YH, Xu G, et al. Characterization of lung function impairment in adults with bronchiectasis. PLoS One. 2014;9:e113373.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hurley MN, Prayle AP, Flume P. Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis. Cochrane Database Syst Rev. 2015;7:CD009730.

    Google Scholar 

  18. Lynch DA, Newell J, Hale V, et al. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. AJR Am J Roentgenol. 1999;173:53–8.

    Article  CAS  PubMed  Google Scholar 

  19. Guan WJ, Gao YH, Xu G, et al. Inflammatory responses, spirometry, and quality of life in subjects with bronchiectasis exacerbations. Respir Care. 2015;60:1180–9.

    Article  PubMed  Google Scholar 

  20. Lopes AJ, Camilo GB, de Menezes SL, et al. Impact of different etiologies of bronchiectasis on the pulmonary function tests. Clin Med Res. 2015;13:12–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Qi Q, Wang W, Li T, et al. Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: a prospective study. Respirology. 2015;20:917–24.

    Article  PubMed  Google Scholar 

  22. King PT, Holdsworth SR, Freezer NJ, et al. Lung diffusing capacity in adult bronchiectasis: a longitudinal study. Respir Care. 2010;55:1686–92.

    PubMed  Google Scholar 

  23. Guan WJ, Gao YH, Xu G, et al. Bronchodilator response in adults with bronchiectasis: correlation with clinical parameters and prognostic implications. J Thorac Dis. 2016;8:14–23.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lee AL, Button BM, Ellis S, et al. Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med. 2009;103:780–5.

    Article  CAS  PubMed  Google Scholar 

  25. Guan WJ, Gao YH, Xu G, et al. Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants. Curr Med Res Opin. 2015;31:843–52.

    Article  PubMed  Google Scholar 

  26. Kharitonov SA, Wells AU, O'Connor BJ, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med. 1995;151:1889–93.

    Article  CAS  PubMed  Google Scholar 

  27. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J. 1998;12:1290–4.

    Article  CAS  PubMed  Google Scholar 

  28. Foley SC, Hopkins NO, Fitzgerald MX, et al. Airway nitric oxide output is reduced in bronchiectasis. Respir Med. 2007;101:1549–55.

    Article  PubMed  Google Scholar 

  29. Cho YJ, Lim HJ, Park JS, et al. Measurement of fractional exhaled nitric oxide in stable bronchiectasis. Tuberc Respir Dis (Seoul). 2013;74:7–14.

    Article  Google Scholar 

  30. Chen FJ, Liao H, Huang XY, et al. Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma. J Thorac Dis. 2016;8:992–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Guan WJ, Yuan JJ, Gao YH, et al. Maximal mid-expiratory flow is a surrogate marker of lung clearance index for assessment of adults with bronchiectasis. Sci Rep. 2016;6:28467.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Guan WJ, Gao YH, Xu G, et al. Impulse oscillometry in adults with bronchiectasis. Ann Am Thorac Soc. 2015;12:657–65.

    Article  PubMed  Google Scholar 

  33. Guan WJ, Yuan JJ, Gao YH, et al. Impulse Oscillometry and Spirometry small-airway parameters in mild to moderate bronchiectasis. Respir Care. 2016;61:1513–22.

    Article  PubMed  Google Scholar 

  34. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(Suppl 1):i1–58.

    Article  PubMed  Google Scholar 

  35. Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576–85.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Martínez-García MÁ, de Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43:1357–67.

    Article  PubMed  Google Scholar 

  37. Courtney JM, Kelly MG, Watt A, et al. Quality of life and inflammation in exacerbations of bronchiectasis. Chron Respir Dis. 2008;5:161–8.

    Article  CAS  PubMed  Google Scholar 

  38. Sugianto TD, Chan HK. Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives. Expert Opin Drug Deliv. 2016;13:7–22.

    Article  CAS  PubMed  Google Scholar 

  39. Clinkscale D, Spihlman K, Watts P, et al. A randomized trial of conventional chest physical therapy versus high frequency chest wall compressions in intubated and non-intubated adults. Respir Care. 2012;57:221–8.

    PubMed  Google Scholar 

  40. Prys-Picard CO, Niven R. Urinary incontinence in patients with bronchiectasis. Eur Respir J. 2006;27:866–7.

    Article  CAS  PubMed  Google Scholar 

  41. Kuzniar TJ, Morgenthaler TI, Afessa B, et al. Chronic cough from the patient’s perspective. Mayo Clin Proc. 2007;82:56–60.

    Article  PubMed  Google Scholar 

  42. Wilson CB, Jones PW, O’Leary CJ, et al. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J. 1997;10:1754–60.

    Article  CAS  PubMed  Google Scholar 

  43. Bahali K, Gedik AH, Bilgic A, et al. The relationship between psychological symptoms, lung function and quality of life in children and adolescents with non-cystic fibrosis bronchiectasis. Gen Hosp Psychiatry. 2014;36:528–32.

    Article  PubMed  Google Scholar 

  44. Mandal P, Morice AH, Chalmers JD, et al. Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis. Respir Med. 2013;107:1008–13.

    Article  CAS  PubMed  Google Scholar 

  45. Eshed I, Minski I, Katz R, et al. (2007) Bronchiectasis: correlation of high-resolution CT findings with health-related quality of life. Clin Radiol. 2007;62:152–9.

    Article  CAS  PubMed  Google Scholar 

  46. Martínez-García MA, Perpiñá-Tordera M, Román-Sánchez P, et al. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest. 2005;128:739–45.

    Article  PubMed  Google Scholar 

  47. Smith MP, Hill AT. Evaluating success of therapy for bronchiectasis: what end points to use? Clin Chest Med. 2012;33:329–49.

    Article  PubMed  Google Scholar 

  48. Wilson CB, Jones PW, O’Leary CJ, et al. Validation of the St. George’s respiratory questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):536–41.

    Article  CAS  PubMed  Google Scholar 

  49. Chan SL, Chan-Yeung MM, Ooi GC, et al. Validation of the Hong Kong Chinese version of the St. George respiratory questionnaire in patients with bronchiectasis. Chest. 2002;122:2030–7.

    Article  PubMed  Google Scholar 

  50. Murray MP, Turnbull K, MacQuarrie S. Validation of the Leicester cough questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34:125–31.

    Article  CAS  PubMed  Google Scholar 

  51. Spinou A, Fragkos KC, Lee KK, et al. The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis. Thorax. 2016;71:683–94.

    Article  PubMed  Google Scholar 

  52. Quittner AL, Marciel KK, Salathe MA, et al. A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis. Chest. 2014;146:437–48.

    Article  PubMed  Google Scholar 

  53. Quittner AL, Marciel KK, Barker AF Quality of Life-Bronchiectasis. The measure is available publicly at: http://www.psy.miami.edu/qol_b/; 2013.

  54. Olveira C, Olveira G, Espildora F, et al. Validation of a quality of life questionnaire for bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0. Qual Life Res. 2014;23:1279–92.

    Article  PubMed  Google Scholar 

  55. Quittner AL, O'Donnell AE, Salathe MA, et al. Quality of life questionnaire-bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 2015;70:12–20.

    Article  PubMed  Google Scholar 

  56. Spinou A, Siegert R, Patel A, et al. The development and validation of the bronchiectasis health questionnaire (BHQ). Eur Respir J. 2016;48:PA2555.

    Google Scholar 

  57. Ogilvie AG. The natural history of bronchiectasis: a clinical, roentgenologic and pathologic study. Arch Intern Med. 1941;68:395–465.

    Article  Google Scholar 

  58. Sánchez-Muñoz G, López de Andrés A, Jiménez-García R, et al. Time trends in hospital admissions for bronchiectasis: analysis of the Spanish national hospital discharge data (2004 to 2013). PLoS One. 2016;11:e0162282.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Goeminne PC, Nawrot TS, Ruttens D, et al. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med. 2014;108:287–96.

    Article  CAS  PubMed  Google Scholar 

  60. Bellelli G, Chalmers JD, Sotgiu G, et al. Characterization of bronchiectasis in the elderly. Respir Med. 2016;119:13–9.

    Article  PubMed  Google Scholar 

  61. Aliberti S, Lonni S, Dore S, et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J. 2016;47:1113–22.

    Article  PubMed  Google Scholar 

  62. Martínez-García MÁ, Vendrell M, Girón R, et al. The multiple faces of non-cystic fibrosis bronchiectasis. A cluster analysis approach. Ann Am Thorac Soc. 2016;13:1468–75.

    Article  PubMed  Google Scholar 

  63. Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007;132:1565–72.

    Article  PubMed  Google Scholar 

  64. King PT, Holdsworth SR, Freezer NJ, et al. Outcome in adult bronchiectasis. COPD. 2005;2:27–34.

    Article  PubMed  Google Scholar 

  65. Finklea JD, Khan G, Thomas S, et al. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. Respir Med. 2010;104:816–21.

    Article  PubMed  Google Scholar 

  66. Goeminne PC, Bijnens E, Nemery B, et al. Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis. Respir Res. 2014;15:108.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Chalmers JD, Aliberti S, Polverino E, et al. The EMBARC European bronchiectasis registry: protocol for an international observational study. ERJ Open Res. 2016;2:1.

    Article  Google Scholar 

  68. Lonni S, Chalmers JD, Goeminne PC, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12:1764–70.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380:660–7.

    Article  CAS  PubMed  Google Scholar 

  70. Altenburg J, de Graaff CS, Stienstra Y, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA. 2013;309:1251–9.

    Article  CAS  PubMed  Google Scholar 

  71. Lee AL, Hill CJ, McDonald CF, et al. Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: a systematic review. Arch Phys Med Rehabil. 2016;98(4):774–782.e1.

    Article  PubMed  Google Scholar 

  72. Mitchell JD, Yu JA, Bishop A, et al. Thoracoscopic lobectomy and segmentectomy for infectious lung disease. Ann Thorac Surg. 2012;93:1033–40.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary Diseases and Critical Care, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA

    Diego J. Maselli & Marcos I. Restrepo

  2. South Texas Veterans Healthcare System, University of Texas Health Science Center, San Antonio, TX, 78229, USA

    Marcos I. Restrepo

Authors
  1. Diego J. Maselli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcos I. Restrepo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diego J. Maselli .

Editor information

Editors and Affiliations

  1. College of Medicine, University of Dundee , Dundee, United Kingdom

    James Chalmers

  2. Hospital Vall D’Hebron, Vall D’Hebron Research Institute (VHIR) Respiratory Disease Department, Barcelona, Spain

    Eva Polverino

  3. Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

    Stefano Aliberti

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Maselli, D.J., Restrepo, M.I. (2018). Clinical Aspects. In: Chalmers, J., Polverino, E., Aliberti, S. (eds) Bronchiectasis. Springer, Cham. https://doi.org/10.1007/978-3-319-61452-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61452-6_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61451-9

  • Online ISBN: 978-3-319-61452-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation